The Pharmaceutics experts at Charles River work closely with the chemistry, biology and DMPK teams to provide essential information on the physical properties of compounds in order to help direct medicinal chemistry activities and to de-risk candidate molecules with respect to their pharmaceutical developability.

Ready, Aim, CRISPR (or RNAi)

The choice of whether to use RNAi or CRISPR often hinges on the details of the experimental questions.

Read the article »

I need to...